Eli Lilly and Company (LLY) : The money flow analysis of Eli Lilly and Company (LLY) indicates a $48.17 million of outflow was on downticks, whereas, the investors on Friday gobbled up stocks worth $66.05 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.37 and so was the total money flow at $17.88 million. A solid up-down ratio of 6.63 in block trades indicates that the investors are accumulating the stock on weakness. The bulls lapped up $25.07 million worth of block trades on upticks. Only $3.78 million worth of the stock exchanged hands on downticks. The money flow was $21.29 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of Eli Lilly and Company (LLY), pushing it down by -0.49% for the day. The stock slid $0.38 and traded at $76.85 during the day. Nonetheless, the stock is -1.78% over the previous weeks close.
The company Insiders own 0.2% of Eli Lilly and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -1.03% . Institutional Investors own 75.27% of Eli Lilly and Company shares. During last six month period, the net percent change held by insiders has seen a change of -1.64%.
In a related news, The Securities and Exchange Commission has divulged in a Form 4 filing that the director of Lilly Eli & Co, Tai Jackson P had purchased shares worth of $463,630 in a transaction dated on August 11, 2016. A total of 5,773 shares were purchased at a price of $80.31 per share. The information is based on open market trades at the market prices.Option exercises are not covered.
Eli Lilly and Company (NYSE:LLY): stock was range-bound between the intraday low of $76.45 and the intraday high of $77.63 after having opened at $77.52 on Fridays session. The stock finally closed in the red at $77.52, a loss of -0.49%. The stock remained in the red for the whole trading day. The total traded volume was 3,943,353 shares. The stock failed to cross $77.63 in Fridays trading. The stocks closing price on Thursday was $77.23.
Eli Lilly and Company (LLY) : During the past 4 weeks, traders have been relatively bearish on Eli Lilly and Company (LLY), hence the stock is down -5.65% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.27% relative to the S&P 500. The 4-week change in the price of the stock is -5.77% and the stock has fallen -1.78% in the past 1 week.
Eli Lilly and Company (Lilly) is engaged in drug manufacturing business. The Company discovers, develops, manufactures and market products in two segments: human pharmaceutical products and animal health products. The Companys products are sold in approximately 120 countries. The Companys human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Companys Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico and 11 other countries. Its products include endocrinology products, neuroscience products, oncology products, cardiovascular products, products for food animals, products for companion animals and Novartis AH products.